azides has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azizian, NG; Chen, J; Li, Y; Molleur, D; Nie, L; Pardo, S; Sullivan, DK; Weintraub, ST | 1 |
| Aich, U; Almaraz, RT; Bhattacharya, R; Khanna, HS; Shah, S; Tan, E; Yarema, KJ | 1 |
2 other study(ies) available for azides and Pancreatic Neoplasms
| Article | Year |
|---|---|
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer
Topics: Amino Acids; Amino Acyl-tRNA Synthetases; Azides; Carcinoma, Pancreatic Ductal; Humans; Pancreatic Neoplasms; Proteome; Tumor Microenvironment | 2021 |
Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
Topics: Acylation; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Azides; Breast Neoplasms; Butyric Acid; Cell Cycle; Cell Line, Tumor; CHO Cells; Click Chemistry; Cricetinae; Cricetulus; Drug Design; Glycocalyx; Glycoconjugates; Hexosamines; Humans; Jurkat Cells; Ketones; Molecular Structure; N-Acetylneuraminic Acid; Pancreatic Neoplasms; Structure-Activity Relationship | 2012 |